欧美午夜精品久久久久免费视-亚洲国产精品无码久久久-鲁鲁狠狠狠7777一区二区-特黄aaaaaaa片免费视频

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Cyclic AMP, also known as cAMP, is a vital second messenger molecule that plays a crucial role in intracellular signal transduction in various organisms. It is involved in the regulation of numerous cellular processes, including cell growth, differentiation, and apoptosis. The cAMP-dependent pathway allows cells to respond to extracellular signals, such as hormones and neurotransmitters, by modulating the activity of protein kinases and other target proteins.

60-92-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Cyclic AMP CAS 60-92-4 3'-5' Cyclic adenosine monophosphate CAS no 60-92-4 Adenosine 3′,5′-cyclic monophosphate

    Cas No: 60-92-4

  • USD $ 3.5-5.0 / Kiloliter

  • 5 Kiloliter

  • 3000 Metric Ton/Month

  • Chemwill Asia Co., Ltd.
  • Contact Supplier
  • 60-92-4 Structure
  • Basic information

    1. Product Name: Cyclic AMP
    2. Synonyms: 5’-cyclicmonophosphate;6-(6-Amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide;Acrasin;Adenosine 3',5'-cyclophosphate;Adenosine 3',5'-phosphate;Adenosine cyclic 3',5'-monophosphate;Adenosine cyclic 3',5'-phosphate;Adenosine cyclic monophosphate
    3. CAS NO:60-92-4
    4. Molecular Formula: C10H12N5O6P
    5. Molecular Weight: 329.21
    6. EINECS: 200-492-9
    7. Product Categories: Pharmaceutical Intermediates;Nucleotides and Nucleic Acids;Nucleic acids
    8. Mol File: 60-92-4.mol
  • Chemical Properties

    1. Melting Point: 260 °C (dec.)(lit.)
    2. Boiling Point: 56.12°C
    3. Flash Point: 378 °C
    4. Appearance: white/powder
    5. Density: 2.47 g/cm3
    6. Vapor Pressure: 1.18E-20mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: 2-8°C
    9. Solubility: H2O: 10 mg/mL pH of aqueous solution is approx. 3.0. The so
    10. PKA: 1.00±0.60(Predicted)
    11. Water Solubility: 50 mg/mL
    12. Merck: 14,2708
    13. BRN: 52645
    14. CAS DataBase Reference: Cyclic AMP(CAS DataBase Reference)
    15. NIST Chemistry Reference: Cyclic AMP(60-92-4)
    16. EPA Substance Registry System: Cyclic AMP(60-92-4)
  • Safety Data

    1. Hazard Codes: C,Xi
    2. Statements: 34-36/37/38
    3. Safety Statements: 22-24/25-45-36/37/39-26-36
    4. WGK Germany: 3
    5. RTECS: AU7357600
    6. F: 10-21
    7. TSCA: Yes
    8. HazardClass: N/A
    9. PackingGroup: N/A
    10. Hazardous Substances Data: 60-92-4(Hazardous Substances Data)

60-92-4 Usage

Uses

Used in Cellular Signaling:
Cyclic AMP is used as a second messenger for intracellular signal transduction in many different organisms. It conveys the cAMP-dependent pathway, allowing cells to respond to extracellular signals and regulate various cellular processes.
Used in Cancer Research:
Cyclic AMP is used in the restoration of several morphological characteristics of normal fibroblasts in sarcoma cells when treated with adenosine-3':5'-cyclic monophosphate. This suggests its potential role in cancer research and the development of therapeutic strategies.
Used in Protein Kinase Regulation:
Used in Platelet Function:
Cyclic AMP is used to stimulate calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate. This highlights its potential role in platelet function and blood clotting mechanisms.

Safety Profile

Human mutation data reported.When heated to decomposition it emits toxic fumes ofPOx and NOx.

Synthesis

Cyclic AMP is synthesized from ATP by adenylate cyclase located on the inner side of the plasma membrane and anchored at various locations in the interior of the cell.[1] Adenylate cyclase is activated by a range of signaling molecules through the activation of adenylate cyclase stimulatory G (Gs)-protein-coupled receptors. Adenylate cyclase is inhibited by agonists of adenylate cyclase inhibitory G (Gi)-protein-coupled receptors. Liver adenylate cyclase responds more strongly to glucagon, and muscle adenylate cyclase responds more strongly to adrenaline. cAMP decomposition into AMP is catalyzed by the enzyme phosphodiesterase.

Check Digit Verification of cas no

The CAS Registry Mumber 60-92-4 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 6 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 60-92:
(4*6)+(3*0)+(2*9)+(1*2)=44
44 % 10 = 4
So 60-92-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/p-1/t4-,6-,7-,10-/m1/s1

60-92-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A2381)  Adenosine 3',5'-Cyclic Monophosphate Hydrate  >99.0%(HPLC)

  • 60-92-4

  • 1g

  • 990.00CNY

  • Detail
  • TCI America

  • (A2381)  Adenosine 3',5'-Cyclic Monophosphate Hydrate  >99.0%(HPLC)

  • 60-92-4

  • 5g

  • 3,490.00CNY

  • Detail
  • Sigma

  • (A9501)  Adenosine3′,5′-cyclicmonophosphate  ≥98.5% (HPLC), powder

  • 60-92-4

  • A9501-1G

  • 2,439.45CNY

  • Detail
  • Sigma

  • (A9501)  Adenosine3′,5′-cyclicmonophosphate  ≥98.5% (HPLC), powder

  • 60-92-4

  • A9501-5G

  • 9,313.20CNY

  • Detail
  • Sigma

  • (A9501)  Adenosine3′,5′-cyclicmonophosphate  ≥98.5% (HPLC), powder

  • 60-92-4

  • A9501-25G

  • 28,629.90CNY

  • Detail

60-92-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3',5'-cyclic AMP

1.2 Other means of identification

Product number -
Other names Adenosine cyclic 3‘,5‘-(hydrogen phosphate)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60-92-4 SDS

60-92-4Synthetic route

C22H38N6O6P(1+)

C22H38N6O6P(1+)

methyl iodide
74-88-4

methyl iodide

A

O3',O5'-methoxyphosphoryl-adenosine
58937-08-9, 62742-70-5, 62989-52-0

O3',O5'-methoxyphosphoryl-adenosine

B

O3',O5'-hydroxyphosphoryl-1-methyl-6,N6-didehydro-1,6-dihydro-adenosine
50884-82-7

O3',O5'-hydroxyphosphoryl-1-methyl-6,N6-didehydro-1,6-dihydro-adenosine

C

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With sodium carbonate In N,N-dimethyl acetamide at 80℃; for 0.0833333h; Yields of byproduct given;A 68.5%
B n/a
C n/a
benzyl bromide
100-39-0

benzyl bromide

C22H38N6O6P(1+)

C22H38N6O6P(1+)

A

(4aR,6R,7R,7aS)-6-(1-Benzyl-6-imino-1,6-dihydro-purin-9-yl)-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol
55053-32-2

(4aR,6R,7R,7aS)-6-(1-Benzyl-6-imino-1,6-dihydro-purin-9-yl)-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

B

(4aR,6R,7R,7aS)-6-(1-Benzyl-6-imino-1,6-dihydro-purin-9-yl)-2-benzyloxy-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol
137157-07-4

(4aR,6R,7R,7aS)-6-(1-Benzyl-6-imino-1,6-dihydro-purin-9-yl)-2-benzyloxy-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol

C

cAMP
60-92-4

cAMP

D

cAMP benzyl ester
62742-71-6

cAMP benzyl ester

Conditions
ConditionsYield
With sodium carbonate In N,N-dimethyl acetamide at 80℃; for 0.25h;A n/a
B 0.7%
C n/a
D 34%
With sodium carbonate In N,N-dimethyl acetamide at 80℃; for 0.25h; Product distribution; other alkyl halide; var. inorganic carbonates;A 2 % Chromat.
B 5 % Chromat.
C 17 % Chromat.
D 74 % Chromat.
C10H12Cl2N5O5P
34051-17-7

C10H12Cl2N5O5P

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With potassium hydroxide In water; acetonitrile at 0℃; Yield given;
2-carboxy-1,N6-etheno adenosine 3',5'-cyclic phosphate
73706-11-3

2-carboxy-1,N6-etheno adenosine 3',5'-cyclic phosphate

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In dimethyl sulfoxide Heating; role of the 1,N6-etheno bridge in decarboxylation (without that decarboxylation did not take place at all);
desyl adenosine cyclic 3',5'-phosphate
143546-26-3

desyl adenosine cyclic 3',5'-phosphate

A

2-phenylbenzofuran
1839-72-1

2-phenylbenzofuran

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In 1,4-dioxane; water Quantum yield; Rate constant; Mechanism; Irradiation; var. solvents, var. pH;
With Tris buffer In water-d2 at 40℃; Quantum yield; Irradiation;
<4-(7-Methoxycoumarinyl)>methyl adenosine cyclic 3',5'-monophosphate

<4-(7-Methoxycoumarinyl)>methyl adenosine cyclic 3',5'-monophosphate

A

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran
72433-26-2

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With water In 1,4-dioxane Irradiation;
equatorial-(7-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

equatorial-(7-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran
72433-26-2

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With HEPES buffer In methanol; water Quantum yield; photolytic cleavage; UV-irradiation;
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-(7-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

axial-(7-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran
72433-26-2

6-methoxy-1-hydroxymethyl-3-oxo-3H-benzopyran

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With HEPES buffer In methanol; water Quantum yield; photolytic cleavage; UV-irradiation;
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

adenylate-cyclase

adenylate-cyclase

cAMP
60-92-4

cAMP

AMP

AMP

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With pyridine; tributyl-amine; dicyclohexyl-carbodiimide
ATP( disodium-salt)

ATP( disodium-salt)

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
With barium dihydroxide
adenylate-cyclase

adenylate-cyclase

A

cAMP
60-92-4

cAMP

B

pyrophosphate

pyrophosphate

equatorial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate
339291-47-3

equatorial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
axial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate
339291-37-1

axial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cAMP
339291-49-5

[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cAMP

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cAMP
339291-40-6

[7-(carboxymethoxy)coumarin-4-yl]methyl ester of cAMP

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
cyclic adenosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester
339291-51-9

cyclic adenosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
cyclic adenosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester
339291-41-7

cyclic adenosine-3',5'-monophosphate [6,7-bis(carboxymethoxy)coumarin-4-yl]methyl ester

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In water Quantum yield; Irradiation;
equatorial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate
339291-47-3

equatorial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

A

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one
54711-38-5

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate
339291-37-1

axial-[7-(diethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

A

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one
54711-38-5

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
equatorial-(coumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-29-7

equatorial-(coumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

4-(hydroxymethyl)coumarin
35893-97-1

4-(hydroxymethyl)coumarin

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-(coumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-28-6

axial-(coumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

4-(hydroxymethyl)coumarin
35893-97-1

4-(hydroxymethyl)coumarin

B

cAMP
60-92-4

cAMP

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
equatorial-(6-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-32-2

equatorial-(6-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

4-(hydroxymethyl)-6-methoxycoumarin

4-(hydroxymethyl)-6-methoxycoumarin

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-(6-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-30-0

axial-(6-methoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

4-(hydroxymethyl)-6-methoxycoumarin

4-(hydroxymethyl)-6-methoxycoumarin

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
equatorial-[7-(dimethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

equatorial-[7-(dimethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

7-(dimethylamino)-4-(hydroxymethyl)-2H-chromen-2-one
105567-75-7

7-(dimethylamino)-4-(hydroxymethyl)-2H-chromen-2-one

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-[7-(dimethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

axial-[7-(dimethylamino)coumarin-4-yl]methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

7-(dimethylamino)-4-(hydroxymethyl)-2H-chromen-2-one
105567-75-7

7-(dimethylamino)-4-(hydroxymethyl)-2H-chromen-2-one

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
equatorial-(6,7-dimethoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

equatorial-(6,7-dimethoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

6,7-dimethoxy-4-(hydroxymethyl)coumarin
402755-39-9

6,7-dimethoxy-4-(hydroxymethyl)coumarin

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
axial-(6,7-dimethoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate
402755-34-4

axial-(6,7-dimethoxycoumarin-4-yl)methyl adenosine cyclic 3',5'-monophosphate

A

cAMP
60-92-4

cAMP

B

6,7-dimethoxy-4-(hydroxymethyl)coumarin
402755-39-9

6,7-dimethoxy-4-(hydroxymethyl)coumarin

Conditions
ConditionsYield
In methanol; water pH=7.2; Quantum yield; UV-irradiation;
Diadenosine triphosphate
5959-90-0

Diadenosine triphosphate

A

cAMP
60-92-4

cAMP

B

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

C

adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

D

C20H29N10O17P3

C20H29N10O17P3

Conditions
ConditionsYield
With sodium hydroxide at 90℃; Kinetics; Product distribution; Further Variations:; pH-values;
cAMP
60-92-4

cAMP

calcium dibutyryl cyclic adenosine monophosphate

calcium dibutyryl cyclic adenosine monophosphate

Conditions
ConditionsYield
With calcium chloride In ethanol; water at 20℃; for 0.166667h;96.98%
butanoic acid anhydride
106-31-0

butanoic acid anhydride

cAMP
60-92-4

cAMP

dibutyryl cyclic AMP
362-74-3

dibutyryl cyclic AMP

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 80℃; for 7h; Solvent; Reagent/catalyst; Temperature; Inert atmosphere;96.09%
cAMP
60-92-4

cAMP

adenosine 3',5'-(cyclic)phosphate monosodium salt
37839-81-9

adenosine 3',5'-(cyclic)phosphate monosodium salt

Conditions
ConditionsYield
With sodium hydroxide In water at 40℃; for 0.666667h; pH=6.6 - 6.7; Temperature;96%
cAMP
60-92-4

cAMP

C10H11N5O6P(1-)*0.5Ca(2+)

C10H11N5O6P(1-)*0.5Ca(2+)

Conditions
ConditionsYield
With calcium carbonate In water at 60℃; for 0.833333h; pH=6.7 - 6.8; Reagent/catalyst; Temperature;93.8%
cAMP
60-92-4

cAMP

inosine 3′,5′-cyclic monophosphate
3545-76-4

inosine 3′,5′-cyclic monophosphate

Conditions
ConditionsYield
With phosphate buffer at 25℃; for 5h; AMP deaminase from Aspergillus sp.;93%
cAMP
60-92-4

cAMP

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

2'-O-Tosyl cAMP
77056-11-2

2'-O-Tosyl cAMP

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane Ambient temperature;80%
cAMP
60-92-4

cAMP

Br-cAMP
23583-48-4

Br-cAMP

Conditions
ConditionsYield
With bromine; sodium acetate In water at 20℃; for 24h;76%
With bromine; sodium acetate In water at 20℃; for 25h;76%
With bromine; sodium acetate In water at 20℃; for 24h;
(E)-di-tert-butyl 2-(3-(7-(diethylamino)-4-(((methylsulfonyl)oxy)methyl)-2-oxo-2H-chromen-3-yl)acrylamido)succinate

(E)-di-tert-butyl 2-(3-(7-(diethylamino)-4-(((methylsulfonyl)oxy)methyl)-2-oxo-2H-chromen-3-yl)acrylamido)succinate

cAMP
60-92-4

cAMP

C39H50N7O13P

C39H50N7O13P

Conditions
ConditionsYield
Stage #1: cAMP With tributyl-amine In methanol; ethanol for 1h; Reflux;
Stage #2: (E)-di-tert-butyl 2-(3-(7-(diethylamino)-4-(((methylsulfonyl)oxy)methyl)-2-oxo-2H-chromen-3-yl)acrylamido)succinate In acetonitrile for 2.5h; Reflux;
65%
[Ru2Cl2(N,N′?diphenylformamidinate)3]

[Ru2Cl2(N,N′?diphenylformamidinate)3]

cAMP
60-92-4

cAMP

[Ru2Cl(N,N′?diphenylformamidinate)3(deprotonated adenosine-3′,5′-cyclic monophosphate)]

[Ru2Cl(N,N′?diphenylformamidinate)3(deprotonated adenosine-3′,5′-cyclic monophosphate)]

Conditions
ConditionsYield
In methanol at 20℃; for 25.5h;57%
benzyl bromide
100-39-0

benzyl bromide

cAMP
60-92-4

cAMP

cAMP benzyl ester
62742-71-6

cAMP benzyl ester

Conditions
ConditionsYield
With silver(l) oxide In dimethyl sulfoxide; acetonitrile at 65℃; for 18h;52%
4-(bromomethyl)-7-methoxycoumarin
35231-44-8

4-(bromomethyl)-7-methoxycoumarin

cAMP
60-92-4

cAMP

<4-(7-Methoxycoumarinyl)>methyl adenosine cyclic 3',5'-monophosphate

<4-(7-Methoxycoumarinyl)>methyl adenosine cyclic 3',5'-monophosphate

Conditions
ConditionsYield
With silver(l) oxide In dimethyl sulfoxide; acetonitrile at 60℃; for 45h;44%
(2E)-cyclooct-2’-en-1’-yl 4-nitrophenyl carbonate

(2E)-cyclooct-2’-en-1’-yl 4-nitrophenyl carbonate

cAMP
60-92-4

cAMP

C19H24N5O8P

C19H24N5O8P

Conditions
ConditionsYield
With dmap In N,N-dimethyl-formamide at 30℃; for 18h;38%
cAMP
60-92-4

cAMP

2-bromomethylnaphthyl bromide
939-26-4

2-bromomethylnaphthyl bromide

A

equatorial-2-Naphthylmethyl adenosine cyclic 3',5'-monophosphate

equatorial-2-Naphthylmethyl adenosine cyclic 3',5'-monophosphate

B

axial-2-Naphthylmethyl adenosine cyclic 3',5'-monophosphate

axial-2-Naphthylmethyl adenosine cyclic 3',5'-monophosphate

Conditions
ConditionsYield
With silver(l) oxide In dimethyl sulfoxide; acetonitrile at 60℃; for 45h;A 31%
B 27%
2-(bromomethyl)anthraquinone
7598-10-9

2-(bromomethyl)anthraquinone

cAMP
60-92-4

cAMP

(2-Anthraquinonyl)methyl adenosine cyclic 3',5'-monophosphate

(2-Anthraquinonyl)methyl adenosine cyclic 3',5'-monophosphate

Conditions
ConditionsYield
With silver(l) oxide In dimethyl sulfoxide; acetonitrile at 60℃; for 45h;14%
1-methyl-4-nitrosobenzene
623-11-0

1-methyl-4-nitrosobenzene

cAMP
60-92-4

cAMP

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
at 98℃; zeitlicher Verlauf.Hydrolysis;
at 100℃; zeitlicher Verlauf.Hydrolysis;
cAMP
60-92-4

cAMP

phosphoric acid inosine-3',5'-diyl ester
3545-76-4, 54621-38-4

phosphoric acid inosine-3',5'-diyl ester

Conditions
ConditionsYield
With potassium nitrite; water wss.Loesung vom pH 3;
cAMP
60-92-4

cAMP

A

adenosine monophosphate
84-21-9

adenosine monophosphate

B

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

Conditions
ConditionsYield
With cerium(III) chloride; water at 30℃; Rate constant; Mechanism; pH 8.0; velocity const. - var. pH's dependence;
With buffer pH 7; tris(3-aminopropyl)amine cobalt(III) hydroxo aqua at 25℃; relative rates of hydrolysis to the monoesters 3'-AMP and 5'-AMP; var. cobalt(III)-complexes;
With hydrogenchloride at 90.1℃; Rate constant;
furfural
98-01-1

furfural

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-(6-{[1-Furan-2-yl-meth-(Z)-ylidene]-amino}-purin-9-yl)-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-(6-{[1-Furan-2-yl-meth-(Z)-ylidene]-amino}-purin-9-yl)-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
Iodoethanol
624-76-0

Iodoethanol

cAMP
60-92-4

cAMP

6-Amino-9-((4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-1-(2-hydroxy-ethyl)-9H-purin-1-ium

6-Amino-9-((4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-1-(2-hydroxy-ethyl)-9H-purin-1-ium

Conditions
ConditionsYield
With sodium hydroxide; silver nitrate 1.) water; 2.) DMF, rt, 3 days; Yield given. Multistep reaction;
butanoic acid anhydride
106-31-0

butanoic acid anhydride

cAMP
60-92-4

cAMP

sodium bucladesine

sodium bucladesine

Conditions
ConditionsYield
With barium(II) iodide; sodium perchlorate; triethylamine 1.) pyridine, heating 3-4 min, then Rt, 6 d; 2.) water, methanol, ether; 3.) methanol, acetone; Multistep reaction;
nonan-1-al
124-19-6

nonan-1-al

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[6-Non-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[6-Non-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[1-((E)-But-2-enyl)-6-imino-1,6-dihydro-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[1-((E)-But-2-enyl)-6-imino-1,6-dihydro-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With 2,6-dimethylpyridine; 1,5-Diazabicyclo[5.4.0]undec-5-ene In N,N-dimethyl-formamide at 60℃; for 5h;146 g
caprinaldehyde
112-31-2

caprinaldehyde

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[6-Dec-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[6-Dec-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
heptanal
111-71-7

heptanal

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[6-Hept-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[6-Hept-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
pentanal
110-62-3

pentanal

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-2-Oxo-6-[6-pent-(Z)-ylideneamino-purin-9-yl]-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-2-Oxo-6-[6-pent-(Z)-ylideneamino-purin-9-yl]-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
Octanal
124-13-0

Octanal

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-6-[6-Oct-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-6-[6-Oct-(Z)-ylideneamino-purin-9-yl]-2-oxo-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In acetic acid at 50℃; for 0.5h;
myristylaldehyde
124-25-4

myristylaldehyde

cAMP
60-92-4

cAMP

(4aR,6R,7R,7aS)-2-Oxo-6-[6-tetradec-(Z)-ylideneamino-purin-9-yl]-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

(4aR,6R,7R,7aS)-2-Oxo-6-[6-tetradec-(Z)-ylideneamino-purin-9-yl]-tetrahydro-2λ5-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

Conditions
ConditionsYield
With tributyl-amine In chloroform; acetic acid at 50℃; for 0.5h;

60-92-4Relevant articles and documents

Structure and monomer/dimer equilibrium for the guanylyl cyclase domain of the optogenetics protein RhoGC

Kumar, Ramasamy P.,Morehouse, Benjamin R.,Fofana, Josiane,Trieu, Melissa M.,Zhou, Daniel H.,Lorenz, Molly O.,Oprian, Daniel D.

, p. 21578 - 21589 (2017)

RhoGC is a fusion protein from the aquatic fungus Blastocladiella emersonii, combining a type I rhodopsin domain with a guanylyl cyclase domain. It has generated excitement as an optogenetics tool for the manipulation of cyclic nucleotide signaling pathways. To investigate the regulation of the cyclase activity, we isolated the guanylyl cyclase domain from Escherichia coli with (GCwCCRho) and without (GCRho) the coiledcoil linker. Both constructs were constitutively active but were monomeric as determined by size-exclusion chromatography and analytical ultracentrifugation, whereas other class III nucleotidyl cyclases are functional dimers. We also observed that crystals of GCRho have only a monomer in an asymmetric unit. Dimers formed when crystals were grown in the presence of the non-cyclizable substrate analog 2′,3′-dideoxyguanosine- 5′-triphosphate, MnCl2, and tartrate, but their quaternary structure did not conform to the canonical pairing expected for class III enzymes. Moreover, the structure contained a disulfide bond formed with an active-site Cys residue required for activity. We consider it unlikely that the disulfide would form under intracellular reducing conditions, raising the possibility that this unusual dimer might have a biologically relevant role in the regulation of full-length RhoGC. Although we did not observe it with direct methods, a functional dimer was identified as the active state by following the dependence of activity on total enzymeconcentration. The low affinity observed for GCRhomonomers is unusual for this enzyme class and suggests that dimer formation may contribute to light activation of the full-length protein.

Photochemical Properties of New Photolabile cAMP Derivatives in a Physiological Saline Solution

Furuta, Toshiaki,Torigai, Hiromi,Sugimoto, Masazumi,Iwamura, Michiko

, p. 3953 - 3956 (1995)

Three new photolabile esters of cAMP (2-anthraquinonyl)methyl (1a), (7-methoxycoumarinyl)methyl (2a), and 2-naphthylmethyl (3a), have been developed.The stability and photochemical properties of these derivatives were compared to the previously reported ones in a physiological saline solution (1percent DMSO in Ringer's solution, pH 7.4).We found that 2a had satisfactory stability (t1/2 > 1000 h) in the dark and was photolyzed to release the parent cAMP on 340 nm irradiation (Φapp = 0.10, Ε340 = 6730) more efficiently than previously reported caged cAMPs.A biological test using the melanophores of the medaka (Oryzias latipes) revealed that 2a penetrated into the melanophores, inactive before irradiation and activated to release cAMP upon irradiation.We have developed a new caged cAMP which can be used in the investigation of biological responses regulated by intracellular cAMP concentrations using living cells.

Method for synthesizing cyclic adenosine monophosphate

-

Page/Page column 4-8, (2019/01/24)

The invention discloses a method for synthesizing cyclic adenosine monophosphate, belonging to the field of synthesis of nucleosides in organic chemistry. The method comprises the following reaction steps: with adenylic acid as a raw material, performing one-step cyclization under the action of acetic anhydride so as to obtain acetylated cyclic adenosine monophosphate; and then performing alkalinehydrolysis so as to obtain cyclic adenosine monophosphate. The method only needs two steps of reaction in the whole process, is simple to operate, avoids usage of considerable solvents that are usedin traditional synthesis processes, has been verified in a kg-grade scale and has industrial application prospects.

ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK

-

Paragraph 0166; 0171; 0172; 0208, (2018/08/12)

Provided are a kind of nucleoside analogue compounds, and compositions comprising these compounds and pentostatin, their use for modulating circadian rhythm, preferably, for shifting circadian phase, and methods for modulating circadian rhythm, preferably, for shifting circadian phase via these compounds or the compositions.

Spectral evolution of a photochemical protecting group for orthogonal two-color uncaging with visible light

Olson, Jeremy P.,Banghart, Matthew R.,Sabatini, Bernardo L.,Ellis-Davies, Graham C. R.

supporting information, p. 15948 - 15954 (2013/11/06)

Caged compounds are molecules rendered functionally inert by derivatization with a photochemical protecting group. We describe the design logic behind the development of a diethylaminocoumarin (DEAC) caging chromophore, DEAC450, that absorbs blue light strongly (ε450 = 43,000 M-1 cm-1) and violet light 11-fold more weakly. The absorption minimum is in the wavelength range (340-360 nm) that is traditionally used for photolysis of many widely used nitroaromatic caged compounds (e.g., 4-carboxymethoxy-5,7- dinitroindolinyl(CDNI)-GABA). We used this chromophore to synthesize DEAC450-caged cAMP and found this probe was very stable toward aqueous hydrolysis in the electronic ground state but was photolyzed with a quantum efficiency of 0.78. When DEAC450-cAMP and CDNI-GABA where co-applied to striatal cholinergic interneurons, the caged compounds were photolyzed in an chromatically orthogonal manner using blue and violet light so as to modulate the neuronal firing rate in a bidirectional way.

Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and bordetella pertussis CyaA

Goettle, Martin,Dove, Stefan,Kees, Frieder,Schlossmann, Jens,Geduhn, Jens,Koenig, Burkhard,Shen, Yuequan,Tang, Wei-Jen,Kaever, Volkhard,Seifert, Roland

experimental part, p. 5494 - 5503 (2011/04/16)

Cyclic adenosine 3′,5′-monophosphate (cAMP) and cyclic guanosine 3′,5′-monophosphate (cGMP) are second messengers for numerous mammalian cell functions. The natural occurrence and synthesis of a third cyclic nucleotide (cNMP), cyclic cytidine 3′,5′-monophosphate (cCMP), is a matter of controversy, and almost nothing is known about cyclic uridine 3′,5′-monophosphate (cUMP). Bacillus anthracis and Bordetella pertussis secrete the adenylyl cyclase (AC) toxins edema factor (EF) and CyaA, respectively, weakening immune responses and facilitating bacterial proliferation. A cell-permeable cCMP analogue inhibits human neutrophil superoxide production. Here, we report that EF and CyaA also possess cytidylyl cyclase (CC) and uridylyl cyclase (UC) activity. CC and UC activity was determined by a radiometric assay, using [α-32P]CTP and [α-32P]UTP as substrates, respectively, and by a high-performance liquid chromatography method. The identity of cNMPs was confirmed by mass spectrometry. On the basis of available crystal structures, we developed a model illustrating conversion of CTP to cCMP by bacterial toxins. In conclusion, we have shown both EF and CyaA have a rather broad substrate specificity and exhibit cytidylyl and uridylyl cyclase activity. Both cCMP and cUMP may contribute to toxin actions.

Factors influencing the operational stability of NADPH-dependent alcohol dehydrogenase and an NADH-dependent variant thereof in gas/solid reactors

Kulishova, Liliya,Dimoula, Kerasina,Jordan, Max,Wirtz, Astrid,Hofmann, Diana,Santiago-Schuebel, Beatrix,Fitter, Joerg,Pohl, Martina,Spiess, Antje C.

experimental part, p. 271 - 283 (2011/02/22)

The continuous enzymatic gas/solid bio-reactor serves both for the production of volatile fine chemicals and flavors on an industrial scale and for thermodynamically controlled investigation of substrate and water effects on enzyme preparations for research purposes. Here, we comparatively investigated the molecular effects on the operational stability of NADPH-dependent Lactobacillus brevis alcohol dehydrogenase and an NADH-dependent variant thereof, LbADH G37D, in the gas/solid bioreactor. The reference reaction is the reduction of acetophenone to (R)-1-phenylethanol with concomitant oxidation of 2-propanol to acetone for the purpose of regeneration of the redox cofactor. It could be clearly shown that not the thermostability of the cofactor, but the thermostability of the proteins in the solid dry state govern the order of magnitude of the operational stability of both purified enzymes in the gas/solid reactor at low thermodynamic activity of water and substrate. However, at higher thermodynamic activity the operational stability in the gas/solid reactor is overlaid by stabilizing and destabilizing effects of the substrates that require further investigation. We demonstrated first evidence that the substrate affinity of the two variants in the gas/solid reactor is similar to the affinity in aqueous medium. We could also show that partial unfolding of the proteins with subsequent aggregation are the factors governing protein thermo-in-stability both in the dissolved and in the dry state. Thus, stability investigations of enzymes in the dry state are suggested to predict their basal level of operational stability in gas/solid reactions.

Coumarinylmethyl esters for ultrafast release of high concentrations of cyclic nucleotides upon one- and two-photon photolysis

Hagen, Volker,Dekowski, Brigitte,Nache, Vasilica,Schmidt, Reinhard,Geissler, Daniel,Lorenz, Dorothea,Eichhorst, Jenny,Keller, Sandra,Kaneko, Hiroshi,Benndorf, Klaus,Wiesner, Burkhard

, p. 7887 - 7891 (2007/10/03)

(Chemical Equation Presented) Shedding light: Efficient activation of cyclic nucleoside monophosphates (cNMPs) can be achieved upon one- and two-photon flash photolysis of novel photolabile coumarinylmethyl esters of cAMP and cGMP (A = adenosine, G = guanosine) as well as their 8-bromosubstituted derivatives. The phototriggers show high solubility in water and permit space- and time-resolved investigations of the molecular mechanisms of cyclic nucleotide dependent processes.

Hydrolytic reactions of diadenosine 5′,5′-triphosphate

Mikkola, Satu

, p. 770 - 776 (2007/10/03)

The hydrolysis of diadenosine 5′,5′-triphosphate to AMP and ADP has been studied over a wide pH-range. Under acidic conditions the reaction shows a first-order dependence on the hydronium ion concentration. Below pH 3 the rate-increase begins to level off. From pH 6 to 9 the hydrolysis is slow and pH-independent. Base-catalysed hydrolysis is observed in NaOH-solutions. Under alkaline conditions an intramolecular nucleophilic attack on the phosphate producing 3′,5′-cAMP is also observed, but it is slower than the intermolecular reaction. Depurination of the adenosine moieties competes with the hydrolysis both under acidic and alkaline conditions, but the mechanisms are different. The temperature-dependence of the hydrolysis of Ap3A and the depurination of adenosine moieties were studied under acidic conditions, and the activation parameters of the reactions were calculated. The results of the work reflect the fact that the negatively charged polyphosphate group is very resistant towards nucleophilic attack. An efficient catalysis is only observed under acidic conditions, where the phosphate group becomes protonated. General acids or bases did not catalyse the hydrolysis. Furthermore, hydroxide ion catalysed cleavage is only observed at high base concentrations and other negatively charged nucleophiles did not attack the phosphate groups of diadenosine polyphosphates.

Thermodynamics of the hydrolysis reactions of adenosine 3′,5′-(cyclic)phosphate(aq) and phosphoenolpyruvate(aq); the standard molar formation properties of 3′,5′-(cyclic)phosphate(aq) and phosphoenolpyruvate(aq)

Goldberg, Robert N.,Tewari, Yadu B.

, p. 1809 - 1830 (2007/10/03)

Molar calorimetric enthalpy changes ΔrHm(cal) have been measured for the biochemical reactions {cAMP(aq) + H2O(l) = AMP(aq)} and {PEP(aq) + H2O(l) = pyruvate(aq) + phosphate(aq)}. The reactions were catalyzed, respectively, by phosphodiesterase 3prime;,5prime;-cyclic nucleotide and by alkaline phosphatase. The results were analyzed by using a chemical equilibrium model to obtain values of standard molar enthalpies of reaction ΔrHmo for the respective reference reactions {cAMp-(aq) + H2O(l) = HAMP-(aq)} and {PEP3-(aq) + H2O(l) = pyruvate-(aq) + HPO42-(aq)}. Literature values of the apparent equilibrium constants K′ for the reactions {ATP(aq) = cAMP(aq) + pyrophosphate(aq)K {ATP(aq) + pyruvate(aq) = ADP(aq) + PEP(aq)}, and {ATP(aq) + pyruvate(aq) + phosphate(aq) = AMP(aq) + PEP(aq) + pyrophosphate(aq)} were also analyzed by using the chemical equilibrium model. These calculations yielded values of the equilibrium constants K and standard molar Gibbs free energy changes ΔrGmo for ionic reference reactions that correspond to the overall biochemical reactions. Combination of the standard molar reaction property values (K, ΔrH mo, and ΔrGmo) with the standard molar formation properties of the AMP, ADP, ATP, pyrophosphate, and pyruvate species led to values of the standard molar enthalpy ΔfHmo, and Gibbs free energy of formation ΔfGmo and the standard partial molar entropy Smo of the cAMP and PEP species. The thermochemical network appears to be reasonably well reinforced and thus lends some confidence to the accuracy of the calculated property values of the variety of species involved in the several reactions considered herein. Published by Elsevier Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 60-92-4